FDA approves extended-release, single-entity hydrocodone product

Author(s):

On Oct. 25, the U.S. Food and Drug Administration (FDA) approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough to require daily, around-the-clock, long-term treatment and for which alternative treatment options are inadequate.
Read more .

LEAVE A REPLY

Please enter your comment!
Please enter your name here